Deficiency of CD4+ T helper (CD4+ Th) cell numbers and/or functionality, which are usually needed to optimize CD8+ T cell responses,4 has further dampened hope for the generalized effectiveness of conventional vaccine strategies in the vast majority of cancer patients. This evidence concerns the gene CD4 and cancer.